Inogen agrees to sell US oxygen rental business to Rotech for up to $25 million
INGN•Inogen agreed to sell its U.S. oxygen rental business to Rotech Healthcare for up to $25 million in cash, with closing expected in Q4 2026. The business generated $24.3 million in revenue in the first half of 2026, down 9.8% year over year.
1. Sale and supply agreement
Inogen agreed to sell its U.S. oxygen rental business to Rotech Healthcare for up to $25 million in cash, with closing expected in Q4 2026. A long-term supply agreement will place Inogen oxygen concentrators in Rotech’s national distribution network. Contingent on closing, Inogen’s share repurchase authorization is set to increase by $15 million to $45 million.
